Cancer Biomarker Discovery Services
Cancer biomarker discovery plays a crucial role in improving cancer diagnostics, prognosis, and treatment selection. At Alfa Cytology, we are committed to providing accurate and reliable biomarker discovery solutions that pave the way for improved diagnostics and personalized treatments.
Introduction to Cancer Biomarker
Cancer biomarkers are substances or characteristics that can be objectively measured and indicate the presence, progression, or response to therapy of cancer. They can be found in various biological samples, including blood, tissue, and urine.
These biomarkers offer valuable insights into cancer biology, aiding in early detection, diagnosis, prognosis, and treatment monitoring. The identification and validation of cancer biomarkers play a crucial role in the development of targeted therapies and the assessment therapeutic response.
Key Applications of Cancer Biomarker Discovery
Monitoring of drug response
Enhance drug target selection
Insights into the mechanisim
Fluid biomarker selection
Our Services
At Alfa Cytology, we pride ourselves on offering exceptional cancer biomarker discovery services that harness the power of advanced technologies and our expertise in the field. Our services include, but are not limited to:
Blood-based Biomarker Discovery
Our Blood-based Biomarker Discovery Service focuses on analyzing biomarkers present in circulating blood components, such as circulating tumor DNA (ctDNA), exosomes, and proteins. These liquid biopsies offer a non-invasive and dynamic approach to monitor tumor progression, assess treatment response, and identify potential therapeutic targets.
Tissue Biomarker Discovery
Alfa Cytology specializes in utilizing various techniques to thoroughly analyze tissue biomarkers. These techniques include immunohistochemistry (IHC), in situ hybridization, proteomics and so on. By leveraging our expertise in these methods, we can identify and characterize biomarkers that are linked to different tumor subtypes, immune infiltration, angiogenesis, and responses to therapies.
We understand that each research project is unique, requiring tailored solutions to meet specific objectives. We offer customizable services to accommodate the distinct needs of our clients. Whether it's selecting the most appropriate biomarker discovery platform, optimizing assay parameters, or designing validation studies, we collaborate closely with our clients to deliver personalized solutions that align with their research goals.
Workflow of Our Services
Handling and preparation of blood and tissue samples maintaining stringent quality controls.
Sample Collection and Preparation
Robust bioinformatics analysis to identify potential biomarkers followed by rigorous validation using independent sample sets.
Data Analysis and Validation
Biomarker Screening
Utilization of high-throughput screening technologies such as next-generation sequencing, mass spectrometry, and microarrays.
Reporting and Recommendations
Detailed reports with actionable insights and recommendations for further research or clinical trial design.
At Alfa Cytology, we are dedicated to pushing the boundaries of biomarker discovery, revolutionizing cancer diagnostics, and contributing to cancer research. With our comprehensive services, we empower researchers and clinicians to unlock the full potential of cancer biomarkers. If you are interested in our service, please contact us for more details.
For research use only.
Related Services
